Wei Sang Selected Research

Radiotherapy

4/2023	A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance.
3/2022	Engineering Radiosensitizer-Based Metal-Phenolic Networks Potentiate STING Pathway Activation for Advanced Radiotherapy.
1/2022	A Metal-Phenolic Nanosensitizer Performs Hydrogen Sulfide-Reprogrammed Oxygen Metabolism for Cancer Radiotherapy Intensification and Immunogenicity.
11/2021	A metal-polyphenolic nanosystem with NIR-II fluorescence-guided combined photothermal therapy and radiotherapy.
2/2021	Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy.
8/2014	[Clinicopathological significance of Sox17 and β-catenin protein of Wnt in oligodendroglioma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Sang Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 08/2013
16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 08/2018
14	Multiple Myeloma 04/2024 - 10/2019
12	Lymphoma (Lymphomas) 12/2023 - 09/2019
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2016
7	Glioma (Gliomas) 01/2023 - 12/2019
6	Cytokine Release Syndrome 04/2024 - 01/2020
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2011
5	Infections 12/2023 - 10/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 06/2021
3	Inflammation (Inflammations) 01/2023 - 06/2021
3	Leukemia 01/2022 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 05/2011
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2023 - 08/2022
2	Hypoxia (Hypoxemia) 04/2023 - 02/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2015 - 06/2012
1	cell-associated neurotoxicity 04/2024
1	Obesity 03/2024
1	Overweight 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024
1	Epstein-Barr Virus Infections 12/2023
1	Melanoma (Melanoma, Malignant) 04/2023
1	Carcinogenesis 04/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Bites and Stings (Sting) 03/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

29	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2014
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2019
6	CytokinesIBA 02/2023 - 06/2012
5	MetalsIBA 01/2023 - 02/2021
5	PolyphenolsIBA 03/2022 - 10/2019
4	B-Cell Maturation AntigenIBA 04/2024 - 10/2019
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 10/2019
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2020
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
3	AntigensIBA 04/2024 - 01/2021
3	tocilizumab (atlizumab)FDA Link 04/2024 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 03/2024 - 02/2021
3	Ferritins (Ferritin)IBA 01/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 06/2021
3	Asparaginase (Elspar)FDA Link 08/2022 - 10/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2024 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2024 - 01/2022
2	PolymersIBA 04/2023 - 10/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 10/2021
2	GlucocorticoidsIBA 01/2023 - 01/2022
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2022 - 02/2021
2	Single-Chain AntibodiesIBA 01/2022 - 01/2018
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 06/2021
2	HafniumIBA 11/2021 - 02/2021
2	MicroRNAs (MicroRNA)IBA 11/2021 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 02/2021
2	polysulfideIBA 06/2021 - 10/2017
2	ELAV-Like Protein 2IBA 11/2020 - 02/2020
2	ParaffinIBA 11/2020 - 08/2013
2	Inosine Triphosphate (ITP)IBA 10/2015 - 06/2012
2	Complementary DNA (cDNA)IBA 10/2015 - 06/2015
1	E2F Transcription FactorsIBA 01/2024
1	Tenofovir (Viread)FDA Link 12/2023
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 12/2023
1	CPI-0610IBA 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	Serum AlbuminIBA 08/2023
1	catechol (pyrocatechol)IBA 04/2023
1	PlatinumIBA 04/2023
1	LigandsIBA 04/2023
1	CalciumIBA 01/2023
1	BilirubinIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	tislelizumabIBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2023
1	ThymosinIBA 01/2023
1	GSK2837808AIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Lactate Dehydrogenase 5IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 08/2022
1	Drug CombinationsIBA 08/2022
1	InterferonsIBA 03/2022
1	NaGdF4IBA 03/2022
1	Lanthanoid Series Elements (Lanthanides)IBA 03/2022
1	carboxyl radical (COO-)IBA 01/2022

Therapy/Procedure

26	Therapeutics 04/2024 - 09/2019
11	Immunotherapy 04/2024 - 07/2019
7	Hematopoietic Stem Cell Transplantation 01/2023 - 05/2011
6	Radiotherapy 04/2023 - 08/2014
5	Drug Therapy (Chemotherapy) 12/2023 - 08/2014
2	Photothermal Therapy 11/2021 - 06/2021
2	Transplantation 01/2021 - 05/2011